Clinical and virological efficacy of etravirine plus two active Nucleos(t)ide analogs in an heterogeneous HIV-infected population

Item

http://www.wikidata.org/entity/Q28538921

description

2014 nî lūn-bûn

@nan

2014 թուականին հրատարակուած գիտական յօդուած

@hyw

2014 թվականին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical and virological effic ...... eneous HIV-infected population

@ast

Clinical and virological effic ...... eneous HIV-infected population

@en

Clinical and virological effic ...... eneous HIV-infected population

@nl

type

Item

label

Clinical and virological effic ...... eneous HIV-infected population

@ast

Clinical and virological effic ...... eneous HIV-infected population

@en

Clinical and virological effic ...... eneous HIV-infected population

@nl

prefLabel

Clinical and virological effic ...... eneous HIV-infected population

@ast

Clinical and virological effic ...... eneous HIV-infected population

@en

Clinical and virological effic ...... eneous HIV-infected population

@nl

P1476

Clinical and virological effic ...... eneous HIV-infected population

@en

P2093

Fernando Lozano

http://www.w3.org/2001/XMLSchema#string

Francisco Téllez-Pérez

http://www.w3.org/2001/XMLSchema#string

Marcial Delgado-Fernández

http://www.w3.org/2001/XMLSchema#string

Maria A Martinez-Perez

http://www.w3.org/2001/XMLSchema#string

Miguel A López-Ruz

http://www.w3.org/2001/XMLSchema#string

Milagros Garcia-Lázaro

http://www.w3.org/2001/XMLSchema#string

Mohamed O Mohamed-Balghata

http://www.w3.org/2001/XMLSchema#string

Pompeyo Viciana

http://www.w3.org/2001/XMLSchema#string

Sociedad Andaluza de Enfermedades Infecciosas

http://www.w3.org/2001/XMLSchema#string

P2860

A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.

Resistance profile of etravirine: combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies.

Clinical pharmacokinetics and pharmacodynamics of etravirine.

Pharmacokinetic interactions between etravirine and non-antiretroviral drugs.

Etravirine: a review of its use in the management of treatment-experienced patients with HIV-1 infection.

Review of drug interactions with telaprevir and antiretrovirals.

TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1.

Lipid-lowering effect and efficacy after switching to etravirine in HIV-infected patients with intolerance to suppressive HAART.

Efficacy and safety of etravirine at week 96 in treatment-experienced HIV type-1-infected patients in the DUET-1 and DUET-2 trials.

Pharmacokinetics of once-daily etravirine without and with once-daily darunavir/ritonavir in antiretroviral-naive HIV type-1-infected adults.

P304

e97262

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4045564

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0097262

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Javier de la Torre-Lima

Manuel Marquez

José-Antonio Girón-González

Luis Fernando López-Cortés

A Romero Palacios

P577

2014-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273922645

http://www.w3.org/2001/XMLSchema#string

P698

24836963

http://www.w3.org/2001/XMLSchema#string

P921

virology

P932

4023987

http://www.w3.org/2001/XMLSchema#string